It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2013.
2013 | Mumbai, Maharashtra, India | ActiveMaxvita Pharma Private Limited, a active private limited company, was established on 01 July 2013 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299MH2013PTC245064. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Its leadership includes Dipti Tejas Thakur (Director), Tejas Vinay Thakur (Director). Past directors included Sanjay Appasaheb Rote, Vinay Laxman Thakur. It holds ₹2.77 Cr open charges and ₹6.98 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-1/17 Vitta Sanchay Housing Society, Near Rcf Factory, Rcf-Mahul Road, Chembu, R, Mumbai, Maharashtra, 400074.
U24299MH2013PTC245064
245064
01 July 2013
₹2.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Maxvita Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dipti Tejas Thakur | Director | 11 Dec 2015 | Current |
| Tejas Vinay Thakur | Director | 01 Jul 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Nov 2014 | Past |
| Pramod Abcsdd | Director | 22 Feb 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maxvita Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.19% decrease. The company also saw a substantial fall in profitability, with a 65.24% decrease in profit. The company's net worth moved up by a moderate rise of 0.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Maxvita Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹27,650,000.00
₹6,975,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Nov 2019 | Others | ₹2.77 Cr | Open |
| 21 Aug 2015 | Oriental Bank Of Commerce | ₹0.40 M | Satisfied |
| 21 Aug 2015 | Oriental Bank Of Commerce | ₹6.58 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Maxvita Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maxvita Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxvita Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Maxvita Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Maxvita Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with Others amounted to Rs. 2.77 Cr with Charge ID 100302395 was registered on 05 Nov 2019. was recorded as a recent event.
The activity A charge registered on 21 Aug 2015 via Charge ID 10588773 with Oriental Bank Of Commerce was fully satisfied on 05 Nov 2019. was completed.
A charge registered on 21 Aug 2015 via Charge ID 10588771 with Oriental Bank Of Commerce was fully satisfied on 05 Nov 2019. was recorded as a recent event.
The activity Dipti Tejas Thakur was appointed as a Director was appointed as a Director on 11 Dec 2015 & has been associated with this company since 9 years 11 months . was completed.
The CIN of Maxvita Pharma Private Limited is U24299MH2013PTC245064.
Maxvita Pharma Private Limited is headquartered at A-1/17 Vitta Sanchay Housing Society, Near Rcf Factory, Rcf-Mahul Road, Chembu, R, Mumbai, Maharashtra, 400074.
Maxvita Pharma Private Limited was incorporated on 01 July 2013.
The current directors of Maxvita Pharma Private Limited are
The primary industry of Maxvita Pharma Private Limited is Manufacturing.
Maxvita Pharma Private Limited is unlisted.
The authorized capital of Maxvita Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Maxvita Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX